Keudell Novartis Ag Transaction History

Keudell

$415 Million
Q1 2025

A detailed history of Keudell transactions in Novartis Ag stock. As of the latest transaction made, Keudell holds 2,828 shares of NVS stock, worth $316,368. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,828

Previous 2,724 3.82%

Holding current value

$316,368

Previous $265,000 18.87%

% of portfolio

0.08%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	BUY	$97.14 - $115.57 $10,102 - $12,019	104 Added 3.82%	2,828 $315,000
Q4 2024 Jan 23, 2025	BUY	$96.78 - $117.18 $677 - $820	7 Added 0.26%	2,724 $265,000
Q3 2024 Oct 31, 2024	SELL	$106.13 - $120.89 $7,853 - $8,945	-74 Reduced 2.65%	2,717 $312,000
Q2 2024 Jul 16, 2024	SELL	$92.57 - $107.37 $11,663 - $13,528	-126 Reduced 4.32%	2,791 $297,000
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $22,960 - $26,141	-241 Reduced 7.63%	2,917 $282,000
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $1,476 - $1,624	16 Added 0.51%	3,158 $318,000
Q3 2023 Oct 18, 2023	SELL	$94.73 - $105.13 $3,694 - $4,100	-39 Reduced 1.23%	3,142 $320,000
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $9,066 - $10,281	-98 Reduced 2.99%	3,181 $320,000
Q4 2022 Jan 20, 2023	SELL	$75.55 - $92.52 $6,799 - $8,326	-90 Reduced 2.67%	3,279 $0
Q3 2022 Oct 12, 2022	BUY	$74.61 - $87.26 $12,161 - $14,223	163 Added 5.08%	3,369 $256,000
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $73,434 - $85,500	-912 Reduced 22.15%	3,206 $271,000
Q1 2022 Apr 18, 2022	BUY	$80.11 - $90.62 $26,195 - $29,632	327 Added 8.63%	4,118 $361,000
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $12,433 - $13,748	-156 Reduced 3.95%	3,791 $332,000
Q3 2021 Oct 20, 2021	BUY	$81.78 - $95.14 $21,917 - $25,497	268 Added 7.28%	3,947 $323,000
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $15,257 - $16,852	179 Added 5.11%	3,679 $336,000
Q1 2021 Apr 13, 2021	BUY	$83.5 - $98.47 $3,590 - $4,234	43 Added 1.24%	3,500 $299,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $4,449 - $5,382	-57 Reduced 1.62%	3,457 $326,000
Q3 2020 Oct 20, 2020	SELL	$82.14 - $91.0 $25,381 - $28,119	-309 Reduced 8.08%	3,514 $306,000
Q2 2020 Jul 14, 2020	BUY	$80.93 - $91.1 $52,037 - $58,577	643 Added 20.22%	3,823 $334,000
Q1 2020 Apr 20, 2020	BUY	$70.67 - $99.01 $58,020 - $81,287	821 Added 34.8%	3,180 $262,000
Q2 2019 Aug 23, 2019	BUY	$75.4 - $92.8 $177,868 - $218,915	2,359 New	2,359 $209,000
Q2 2019 Aug 21, 2019	SELL	$75.4 - $92.8 $170,328 - $209,635	-2,259 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$75.32 - $86.15 $170,147 - $194,612	2,259 New	2,259 $217,000

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account